Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exelixis, Inc. - Common Stock
(NQ:
EXEL
)
56.00
+0.94 (+1.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exelixis, Inc. - Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
22
23
Next >
Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates
May 03, 2023
From
Farallon Capital Management L.L.C.
Via
Business Wire
Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders
May 01, 2023
From
Exelixis, Inc.
Via
Business Wire
Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 25, 2023
From
Exelixis, Inc.
Via
Business Wire
What 9 Analyst Ratings Have To Say About Exelixis
↗
April 12, 2023
Via
Benzinga
Why Exelixis Stock Leaped More Than 4% Higher Today
↗
March 20, 2023
Oh, how some investors love stock buyback programs.
Via
The Motley Fool
Analyst Ratings for Exelixis
↗
March 20, 2023
Via
Benzinga
2 Stocks to Buy With Less Than $20
↗
March 10, 2023
Some relatively low-priced shares can be good buys, too.
Via
The Motley Fool
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
↗
April 22, 2023
These cheap stocks have the potential to skyrocket over the long haul.
Via
The Motley Fool
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip
↗
April 22, 2023
Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite.
Via
The Motley Fool
Exelixis Advances Board Refreshment Plan
April 13, 2023
From
Exelixis, Inc.
Via
Business Wire
Exelixis Reiterates Commitment to Shareholder Value Creation
April 05, 2023
From
Exelixis, Inc.
Via
Business Wire
The Latest Analyst Ratings for Exelixis
↗
March 03, 2023
Via
Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
↗
April 05, 2023
Both companies have game-changing product portfolios that should result in stock price growth.
Via
The Motley Fool
Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories
↗
April 05, 2023
Benzinga
Via
Benzinga
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
↗
April 05, 2023
Via
Benzinga
Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change
April 05, 2023
From
Farallon Capital Management L.L.C.
Via
Business Wire
2 Incredible Stocks to Buy With Less Than $25
↗
April 04, 2023
Nothing beats a great investment for the price of just a few cups of coffee.
Via
The Motley Fool
Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
↗
March 27, 2023
In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier.
Via
Investor's Business Daily
Exelixis Announces $550 Million Share Repurchase Program
March 20, 2023
From
Exelixis, Inc.
Via
Business Wire
3 Beaten-Down Stocks That Could Soar This Year
↗
March 18, 2023
These stocks could enjoy big rebounds in 2023.
Via
The Motley Fool
Exelixis Stock Generating Improved Relative Strength Rating
↗
March 16, 2023
Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76.
Via
Investor's Business Daily
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
↗
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit
March 13, 2023
From
Exelixis, Inc.
Via
Business Wire
Nasdaq Bear Market: 5 Stunning Growth Stocks You'll Regret Not Buying on the Dip
↗
March 11, 2023
A 33% plunge in the previously high-flying Nasdaq Composite is the perfect time for growth investors to pounce on some amazing deals.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
↗
March 09, 2023
Via
Benzinga
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
↗
March 03, 2023
Via
Benzinga
US Stocks Look To Snap String Of Weekly Losses As Futures Signal Positive Start Ahead Of Service Sector Data, Fed Speeches
↗
March 03, 2023
U.S. stocks have returned to their cautious ways after their resilience performance on Thursday. The major index futures point to a modestly higher opening on Friday. Cues From Thursday’s Trading:
Via
Benzinga
Dell, Zscaler, Marvell Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
March 03, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Exelixis Provides Update on Phase 3 CONTACT-03 Trial Evaluating Cabozantinib in Combination with Atezolizumab in Patients with Previously Treated Advanced Kidney Cancer
March 02, 2023
From
Exelixis, Inc.
Via
Business Wire
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March
February 28, 2023
From
Exelixis, Inc.
Via
Business Wire
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
